Your browser doesn't support javascript.
loading
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal Cancer.
Van Cutsem, Eric; Taieb, Julien; Yaeger, Rona; Yoshino, Takayuki; Grothey, Axel; Maiello, Evaristo; Elez, Elena; Dekervel, Jeroen; Ross, Paul; Ruiz-Casado, Ana; Graham, Janet; Kato, Takeshi; Ruffinelli, Jose C; André, Thierry; Carrière Roussel, Edith; Klauck, Isabelle; Groc, Mélanie; Vedovato, Jean-Claude; Tabernero, Josep.
Afiliação
  • Van Cutsem E; University Hospital Leuven and KU Leuven, Leuven, Belgium.
  • Taieb J; Department of Hepatogastroenterology and Gastrointestinal Oncology, University Paris-cité (Paris Descartes), SIRIC CARPEM, Georges Pompidou European Hospital, AP-HP, Paris, France.
  • Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Grothey A; West Cancer Center and Research Institute, Germantown, TN.
  • Maiello E; Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy.
  • Elez E; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Dekervel J; University Hospital Leuven and KU Leuven, Leuven, Belgium.
  • Ross P; Department of Oncology, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • Ruiz-Casado A; Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.
  • Graham J; Dept of Medical Oncology, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK.
  • Kato T; Department of Colorectal Surgery, National Hospital Organization, Osaka National Hospital, Osaka, Japan.
  • Ruffinelli JC; Institut Català d'Oncologia L'Hospitalet-Hospital, Duran i Reynals, Barcelona, Spain.
  • André T; Sorbonne University; Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France.
  • Carrière Roussel E; Pierre Fabre, Medical & Patient/Consumer Division, Langlade, France.
  • Klauck I; Pierre Fabre, Medical & Patient/Consumer Division, Boulogne, France.
  • Groc M; Pierre Fabre, Medical & Patient/Consumer Division, Langlade, France.
  • Vedovato JC; Pierre Fabre, Medical & Patient/Consumer Division, Langlade, France.
  • Tabernero J; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital, Vall d'Hebron Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain.
J Clin Oncol ; 41(14): 2628-2637, 2023 05 10.
Article em En | MEDLINE | ID: mdl-36763936
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Estados Unidos